Lowest month-to-month tirzepatide
$215/mo
dose-flat, no membership
GLP-1 telehealth price index · United States · dataset 2026-08-09
Find your cheapest verified GLP-1 in 30 seconds.
A lapsed brand refill can bill $699+ a month. The 41 programs in this index run $133–$597 all-in — every figure read from the provider’s own page, dated, archived, and recomputable from the public dataset. No scores you can’t recompute. No placements anyone can buy.
Brand, off-program list
$699+/mo
→
Verified programs, all-in
$133–$597/mo · captured 2026-08-09
30-second match · computed from 22 verified records
#1 VERIFIED PRICENexLife$215/mo tirz
CHEAPEST SEMA · 50-STATEYucca Health$146/mo
BEST INSURANCE PATHRo Body$145/mo membership
NEEDLE-FREE · FDA-APPROVEDOral Wegovyfrom $149/mo
Compounded tirzepatide from $215
Compounded semaglutide from $133*
Brand injectable from $199 intro
Oral pill from $149
Flat at every dose
No membership
Insurance beats all of it →
30-second match quiz
✓ Rankings are sorts of the dataset — nobody can buy a position ✓ 41 records · source-linked · archived ✓ *$133 floor is limited-state (Oak Longevity); $146 is the 50-state floor ✓ affiliate links disclosed, never ranked
Where each superlative actually lands
Lowest semaglutide (broad availability)
$146/mo
lowest overall: Oak Longevity at $133, limited states
Lowest advertised starting price
$133/mo
starter dose only — no maintenance price published, so unranked
Every cell is computed from the public dataset by the published methodology. Change the data and the winners change; nothing here is placed by hand.
Tirzepatide, priced honestly
The verified compounded market runs $215–$597/mo all-in; brand Zepbound vials run $299–$449 direct from Lilly. The spread is structure, not chemistry: memberships, dose tiers, prepaid terms.
Cheapest tirzepatide providers
All 17 verified programs, sorted on the 10 mg all-in basis, with capture dates.
$215+
The market, in plain words
The flagship read: every price in sentences, with the qualifiers each number hides.
Compounded vs Zepbound
The $234/mo gap and exactly what it buys in 2026.
The true 12-month cost
$2,232 to $7,164 for the same year of the same molecule.
Flat vs dose-tiered pricing
The structural choice that decides whether titration is a billing event.
Tirzepatide, the medication
Brand names, the compounding lane after 2025, and the full price landscape.
Semaglutide, the cheaper half
Verified compounded programs from $133/mo; Wegovy direct from Novo at $349 ($199 intro); the oral pill from $149. The brand gap has shrunk to double digits — which changes the whole decision.
The semaglutide market, in prose
Where the floor is, and which caveats it stands on.
Compounded vs Wegovy
A $203-a-month question, answered with the 2026 numbers.
One dataset, 41 programs, every figure dated
Provider, both molecules, start and maintenance prices, membership, shipping, consultation, prepaid terms, commitment, cancellation, pharmacy type, states, insurance, evidence status, capture date, source and archive links — normalized to one basis and free to reuse (CC BY 4.0).
Frequently asked
What is the cheapest GLP-1 medication online right now?
On the 2026-08-09 capture: compounded semaglutide from $133/mo (Oak Longevity, limited states) or $146 broadly (Yucca); compounded tirzepatide from $215/mo (NexLife↗, dose-flat, no membership). Brand floors: Wegovy $349 via NovoCare↗, Zepbound vials $299–$449 via LillyDirect↗. Insurance coverage, where it exists, beats all of these.
How does this site make its rankings?
Mechanically. Programs are sorted by verified all-in monthly price at the maintenance dose — medication plus every mandatory fee — and nothing else reorders a list. The basis, exclusions, and verification cycle are published at /methodology/, and the dataset is downloadable so any ranking can be recomputed by anyone.
Are compounded GLP-1s legal in 2026?
Only in a narrow lane: patient-specific prescriptions at licensed 503A pharmacies with documented clinical need. Mass compounding ended when the FDA shortage declarations were resolved (2024–2025) and enforcement discretion expired; courts upheld the agency, and an April 2026 proposed rule would bar 503B bulk production entirely. Timeline: what happened, date by date.
Why do you rank on the maintenance dose instead of the advertised price?
Because advertised starting prices systematically flatter dose-tiered programs. The lowest advertised figure in our index is $133 — a starter price with no published maintenance figure at all. The maintenance-dose all-in price is the number a real year is billed at, so it is the only number worth ranking on.
Do you take money from the companies you rank?
Rankings cannot be bought, structurally: they are computed from the public dataset by a published sort. Every material relationship between this site and any covered company is disclosed at /ownership-disclosure/, which is linked from every page.
Is this medical advice?
No. This site measures prices and program structures — documentary facts. Whether any GLP-1, brand or compounded, is right for you is a decision for you and a licensed clinician; see the medical disclaimer.